A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241311129 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ronak Shah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Cisplatin, Fanconi Anemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Cancer Society.
Abstract (Originalsprache)
Fanconi anemia (FA) develops due to a mutation in one of the FANC genes that are involved in the repair of interstrand crosslinks (ICLs). FANCG, a member of the FA core complex, is essential for ICL repair. Previous FANCG-deficient mouse models were generated with drug-based selection cassettes in mixed mice backgrounds, leading to a disparity in the interpretation of genotype-related phenotype. We created a Fancg-KO (KO) mouse model using CRISPR/Cas9 to exclude these confounders. The entire Fancg locus was targeted and maintained on the immunological well-characterized C57BL/6J background. The intercrossing of heterozygous mice resulted in sub-Mendelian numbers of homozygous mice, suggesting the loss of FANCG can be embryonically lethal. KO mice displayed infertility and hypogonadism, but no other developmental problems. Bone marrow analysis revealed a defect in various hematopoietic stem and progenitor subsets with a bias towards myelopoiesis. Cell lines derived from Fancg-KO mice were hypersensitive to the crosslinking agents cisplatin and Mitomycin C, and Fancg-KO mouse embryonic fibroblasts (MEFs) displayed increased γ-H2AX upon cisplatin treatment. The reconstitution of these MEFs with Fancg cDNA corrected for the ICL hypersensitivity. This project provides a new, genetically, and immunologically well-defined Fancg-KO mouse model for further in vivo and in vitro studies on FANCG and ICL repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
- Mouse Clinic for Cancer and Aging Transgenic Facility, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
- Department of Experimental Animal Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
ORCID-Profile: Bas Pilzecker, Heinz Jacobs
Förderung
- Dutch Cancer Society
Zitieren
APA
Shah, R., van den Berk, P. C. M., Pritchard, C. E. J., Song, J. Y., Kreft, M., Pilzecker, B., & Jacobs, H. (2023). A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241311129
Vancouver
Shah R, van den Berk PCM, Pritchard CEJ, Song JY, Kreft M, Pilzecker B, et al. A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241311129
BibTeX
@article{Shah2023,
author = {Shah, Ronak and van den Berk, Paul C M and Pritchard, Colin E J and Song, Ji-Ying and Kreft, Maaike and Pilzecker, Bas and Jacobs, Heinz},
title = {A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241311129}
}
EUVIMED